Literature DB >> 8436616

Role of protein kinase C in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage.

M Sako1, J Nishihara, S Ohta, J Wang, S Sakaki.   

Abstract

This study investigated the role of protein kinase C (PKC) in the pathogenesis of vasospasm after experimental subarachnoid hemorrhage (SAH). PKC activation by intracisternal injection of a phorbol ester [12-O-tetradecanoylphorbol-13-acetate (TP)] induced dose-dependent, slowly developing, severe contraction of the basilar artery. A single intracisternal injection of TP (5 x 10(-9) M in the CSF) induced sustained contraction lasting over 3 days, which almost paralleled the changes of membrane-bound PKC activity in the basilar arterial wall. In a two-hemorrhage SAH model, membrane-bound PKC activity in the basilar artery increased up to day 4 and returned to the control level by day 14, whereas angiographic contraction reached a maximum on day 7 and still persisted at a moderate level on day 14. Thus, there was a discrepancy between arterial PKC activity and arterial contraction. Multiple intracisternal injections of TP produced 30-40% sustained contraction of the basilar artery lasting for more than 10 days along with sustained activation of PKC to levels compatible with that observed in the SAH model. However, TP injection caused considerably milder histological changes in the basilar artery than those noted in the SAH model. We concluded that cerebral vasospasm after SAH cannot be explained solely on the basis of activation of the PKC pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436616     DOI: 10.1038/jcbfm.1993.30

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  4 in total

1.  The polycationic aminoglycosides modulate the vasoconstrictive effects of endothelin: relevance to cerebral vasospasm.

Authors:  G Wickman; M A Nessim; D A Cook; B Vollrath
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Possible mechanism to induce protein kinase C-dependent arterial smooth muscle contraction after subarachnoid haemorrhage.

Authors:  S Ohta; J Nishihara; Y Oka; H Todo; Y Kumon; S Sakaki
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 3.  Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Authors:  T Asano; T Matsui
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

4.  Single blood injection into the ventral cisterna magna through a microcatheter for the production of delayed cerebral vasospasm: experimental study in dogs.

Authors:  Takamasa Mizuno; Jun-Ichiro Hamada; Yutaka Kai; Tatemi Todaka; Motohiro Morioka; Yukitaka Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.